We are monitoring the impact of COVID-19 on North America Nuclear Medicine Market Get in touch with us for detailed analysis Know More
Pulished Date April, 2021
ID: 99
Share on
Share on

North America Nuclear Medicine Market Research Report - Segmented By SPECT, PET, Application & Country (the United States, Canada, & Rest of North America) - Industry Analysis on Size, Share, Trends, COVID-19 Impact and Growth Forecast (2021 to 2026)

Pulished: April, 2021
ID: 99
Pages: 143

North America Nuclear Medicine Market Size (2021 to 2026)

The size of the North American nuclear medicine market is estimated to value USD 8.63 billion by 2026 and USD 5.05 billion in 2021, growing at a CAGR of 11.3% during the forecast period.

The Nuclear medicine market in North America is majorly driven by the proliferation of cancer and cardiac ailments and the initiatives to lessen the demand-supply gap of Mo-99. The Nuclear medicine market is most likely to account for the largest share due to nuclear medicine adoption in therapeutics and diagnostics and the growing burden of diseases in the region. Also, increasing government funding and initiatives to develop advanced techniques are most likely to create market growth. For example, in July 2019, the United States government approved the Medicare Diagnostic Radiopharmaceutical Payment Equity Act of 2019. By altering the way Medicare pays for imaging services, the new law intends to provide access to high-targeted, more precise therapy and diagnosis of severe neurological disorders.

In addition, radiopharmaceuticals are widely employed in molecular imaging, a technique in which molecules are used as biomarkers for specific molecular processes that influence the illness's start and progression. During the projected period, this is likely to boost the nuclear medicine market. Increased funding for research and development in Canada is also helping to grow the market. ARTMS Products, a Vancouver-based business, received CAD 26.4 million in Series A funding in May 2020 to finance radiopharmaceutical research and development. Market growth has been supported by technical developments in the field of imaging. Scientists, academics, and engineers have integrated hybrid systems into clinical practice in recent years. A combination of two or more single diagnostic imaging modalities is used. 

Many technical developments, including the advent of a time of flight (ToF) and the rising popularity of hybrid imaging systems, are essential to market development. A new set of regulations has been implemented to ensure the safety of employees at imaging centers and other nuclear plants. The US Food and Drug Administration (US FDA) released guidance in 2020 to help nuclear medicine departments alter their operational practices to decrease the risk of COVID-19 infection among patients, employees, and the general public. 

Radiopharmaceuticals have a limited half-life, which limits their application. At the same time, hospital budget constraints and expensive equipment prices have made nuclear medicine less accessible to some end-users; these factors are expected to impede the market's growth.

This research report on the North America Nuclear Medicine Diagnostics Market is segmented and sub-segmented into the following categories:

By Type:

  • SPECT
  • PET

By Application:

  • Cardiology
  • Lymphoma
  • Thyroid
  • Neurology
  • Oncology
  • others

By Country:

  • United States
  • Canada
  • Rest of North America

During the forecast period, the North American nuclear medicine market is predicted to have the most dominant share globally. The market growth is driven by increasing research and development on nuclear medicine, availability of advanced healthcare infrastructure, and growing awareness about nuclear imaging. North America has witnessed advanced technology in the healthcare sector, which is predicted to impact market growth positively. The key players in this region are implementing multiple strategies to maintain their significant share in nuclear medicine during the forecast period. The strategy implemented includes product developments, business expansion, and collaborative development.

The United States nuclear medicine market is predicted to account for the most significant share in the North American market during the forecast period. An increase in the incidence of chronic diseases such as cardiovascular disease and cancer, favorable reimbursement policies, growing healthcare spending, and advancing healthcare infrastructure in the country influence market growth.

On the other hand, the Canadian nuclear medicine market is predicted to have a moderate share in the forecast period. Growing investment for research and development in Canada also contributes to market expansion. For example, in May 2020, ARTMS Products, a Vancouver-based business, obtained CAD 26.4 million in Series A investment to aid radiopharmaceutical research and production.

KEY MARKET PLAYERS:

A few of the notable companies operating in the North America Nuclear Medicine Diagnostic Market are Cardinal Health, Inc., Bracco Imaging S.p.A, GE Healthcare, Eczacibasi-Monrol Nuclear Products, Nordion, Inc., Bayer Healthcare, Lantheus Medical Imaging, Inc., Advanced Accelerator Applications S.A., IBA Molecular Imaging and Mallinckrodt PLC.

  1. Introduction

                1.1 Market Definition                                                    

                1.2 Study Deliverables                                                  

                1.3 Base Currency, Base Year and Forecast Periods                                                          

                1.4 General Study Assumptions                                                

  1. Research Methodology

                2.1 Introduction                                                               

                2.2 Analysis Design                                                         

                2.3 Research Phases                                                      

                                2.3.1 Secondary Research                                           

                                2.3.2 Primary Research                                 

                                2.3.3 Econometric Modelling                                      

                                2.3.4 Expert Validation                                  

                2.4 Study Timeline                                                          

  1. Overview

                3.1 Executive Summary                                                

                3.2 Key Inferences                                                         

                3.3 New Developments                                               

  1. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)

                4.1 Market Drivers                                                          

                4.2 Market Restraints                                                    

                4.3 Key Challenges                                                         

                4.4 Current Opportunities in the Market                                                              

  1. Market Segmentation

                5.1 By Type                                                        

                                5.1.1 SPECT                                        

                                                5.1.1.1 Technetium-99m                              

                                                5.1.1.2 Thallium-201                       

                                                5.1.1.3 Gallium-67                           

                                                5.1.1.4 Iodine-23                             

                                                5.1.1.5 Others                   

                                5.1.2 PET                                             

                                                5.1.2.1 Fluorine-18                          

                                                5.1.2.2 Rubidium-82                       

                                                5.1.2.3 Others                   

                5.2 By Application                                                           

                                5.2.1 Cardiology                                               

                                5.2.2 Lymphoma                                              

                                5.2.3 Thyroid                                     

                                5.2.4 Neurology                                               

                                5.2.5 Oncology                                 

                                5.2.6 Others                                      

  1. Geographical Analysis

                6.1 Introduction                                                               

                6.2 United States                                                            

                6.3 Canada                                                         

  1. Strategic Analysis

                7.1 PESTLE analysis                                                         

                                7.1.1 Political                                     

                                7.1.2 Economic                                 

                                7.1.3 Social                                         

                                7.1.4 Technological                                         

                                7.1.5 Legal                                          

                                7.1.6 Environmental                                       

                7.2 Porter’s Five analysis                                                              

                                7.2.1 Bargaining Power of Suppliers                                        

                                7.2.2 Bargaining Power of Consumers                                    

                                7.2.3 Threat of New Entrants                                     

                                7.2.4 Threat of Substitute Products and Services                                              

                                7.2.5 Competitive Rivalry within the Industry                                     

  1. Market Leaders' Analysis

                8.1 GE Healthcare                                                           

                                8.1.1 Overview                                 

                                8.1.2 Product Analysis                                   

                                8.1.3 Strategic Evaluation and Operations                                            

                                8.1.4 Financial analysis                                  

                                8.1.5 Legal issues                                             

                                8.1.6 Recent Developments                                       

                                8.1.7 SWOT analysis                                       

                                8.1.8 Analyst View                                          

                8.2 Cardinal Health Inc.                                                 

                8.3 Bracco Imaging S.p.A                                                              

                8.4 Eczacibasi-Monrol Nuclear Products                                                

                8.5 Nordion, Inc.                                                              

                8.6 Bayer Healthcare                                                     

                8.7 Lantheus Medical Imaging, Inc.                                                          

                8.8 Advanced Accelerator Applications S.A.                                                         

                8.9 IBA Molecular Imaging                                                           

                8.10 Mallinckrodt plc.                                                    

  1. Competitive Landscape

                9.1 Market share analysis                                                            

                9.2 Merger and Acquisition Analysis                                                       

                9.3 Agreements, collaborations and Joint Ventures                                                         

                9.4 New Product Launches                                                         

  1. Expert Opinions

                10.1 Market Outlook                                                     

                10.2 Investment Opportunities                                                 

    Appendix                                                                          

  1. List of Tables
  2. List of Figures
  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. North America Nuclear medicine Market, By Region, From 2020 to 2025 (USD Billion)
  2. North America Nuclear medicine Market, By Type, From 2020 to 2025 (USD Billion)
  3. North America SPECT Diagnostic Radioisotopes Market, By Region, From 2020 to 2025 (USD Billion)
  4. North America PET Diagnostic Radioisotopes Market, By Region, From 2020 to 2025 (USD Billion)
  5. North America Nuclear medicine Market, By Application, From 2020 to 2025 (USD Billion)
  6. North America Cardiology Market, By Region, From 2020 to 2025 (USD Billion)
  7. North America Lymphoma Market, By Region, From 2020 to 2025 (USD Billion)
  8. North America Thyroid Market, By Region, From 2020 to 2025 (USD Billion)
  9. North America Neurology Market, By Region, From 2020 to 2025 (USD Billion)
  10. North America Oncology Market, By Region, From 2020 to 2025 (USD Billion)
  11. North America Other Applications Market, By Region, From 2020 to 2025 (USD Billion)
  12. North America SPECT Diagnostic Radioisotopes Market, By Type, From 2021 to 2026 (USD Billion)
  13. North America Technetium-99m Market, By Region, From 2021 to 2026 (USD Billion)
  14. North America Thallium-201 Market, By Region, From 2021 to 2026 (USD Billion)
  15. North America Gallium-67 Market, By Region, From 2021 to 2026 (USD Billion)
  16. North America Iodine-23 Market, By Region, From 2021 to 2026 (USD Billion)
  17. North America Other SPECT Diagnostic Radioisotopes Market, By Region, From 2021 to 2026 (USD Billion)
  18. North America PET Diagnostic Radioisotopes Market, By Type, From 2021 to 2026 (USD Billion)
  19. North America Fluorine-18 Market, By Region, From 2021 to 2026 (USD Billion)
  20. North America Rubidium-82 Market, By Region, From 2021 to 2026 (USD Billion)
  21. North America Other PET Diagnostic Radioisotopes Market, By Region, From 2021 to 2026 (USD Billion)
  22. United States Nuclear medicine Market, By Type, From 2020 to 2025 (USD Billion)
  23. United States Nuclear medicine Market, By Application, From 2020 to 2025 (USD Billion)
  24. Canada Nuclear medicine Market, By Type, From 2020 to 2025 (USD Billion)
  25. Canada Nuclear medicine Market, By Application, From 2020 to 2025 (USD Billion)
  26. United States SPECT Diagnostic Radioisotopes Market, By Type, From 2021 to 2026 (USD Billion)
  27. Canada SPECT Diagnostic Radioisotopes Market, By Type, From 2021 to 2026 (USD Billion)
  28. United States PET Diagnostic Radioisotopes Market, By Type, From 2021 to 2026 (USD Billion)
  29. Canada PET Diagnostic Radioisotopes Market, By Type, From 2021 to 2026 (USD Billion)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample